Table 1.
Age | 12.4 ± 4.8 years |
Gender | |
Male | 57% |
Female | 43% |
T1D duration | 6.1 ± 3.7 years |
Mode of insulin delivery | |
Injections | 35% |
Insulin pump | 65% |
SMBG per day | |
Before CGM initiation | 6.3 ± 2.9 |
6 Months post-CGM initiation for those continuing CGM use (n = 30) | 6.5 ± 3.8 |
Mean HbA1c | |
Before CGM initiation | 8.2 ± 1.2% |
6 Months post-CGM initiation for those continuing CGM use (n = 27) | 8.2 ± 1.3% |
Ethnicity | |
Caucasian | 37% |
Minority | 63% |
Primary language | |
English | 85% |
Other | 15% |
Method for viewing CGM data | |
iOS device | 17% |
Dexcom receiver | 73% |
CGM, continuous glucose monitoring; HbA1c, hemoglobin A1c; SMBG, self-monitoring of blood glucose; T1D, type 1 diabetes.